Logo
x

Search

Subscribe Now

Bispecific

Roche Highlights its Bispecific Antibody Portfolio Across a Range of Blood Cancers at ASH 2020

Roche Highlights its Bispecific Antibody Portfolio Across a Range of Blood Cancers at ASH 2020

  • December 9, 2020
Astellas Signs a Research and License Agreement with Xencor for Bispecific Antibody Program in Oncology

Astellas Signs a Research and License Agreement with Xencor for Bispecific Antibody Program in Oncology

  • April 3, 2019
Image

Incisive News in 3 Shots.

Contact Us

Our Information

Follow Us

Copyright © 2024 PharmaShots - All Rights Reserved.